For the current REF see the REF 2021 website REF 2021 logo

Output details

1 - Clinical Medicine

University of Nottingham

Return to search Previous output Next output
Output 0 of 0 in the submission
Article title

Methylprednisolone in combination with interferon beta-1a for relapsing-remitting multiple sclerosis (MECOMBIN study): a multicentre, double-blind, randomised, placebo-controlled, parallel-group trial

Type
D - Journal article
Title of journal
Lancet Neurology
Article number
-
Volume number
9
Issue number
7
First page of article
672
ISSN of journal
1474-4422
Year of publication
2010
Number of additional authors
10
Additional information

a. The author made a substantial contribution to the conception and design of the study; to the organisation of the conduct of the study; to carrying out the study (including acquisition of study data); to analysis and interpretation of study data.

and

b. The author helped draft the output; critique the output for important intellectual content.

Interdisciplinary
-
Cross-referral requested
-
Research group
None
Citation count
26
Proposed double-weighted
No
Double-weighted statement
-
Reserve for a double-weighted output
No
Non-English
No
English abstract
-